Application 219556
- Type
- ANDA
- Sponsor
- EPIC PHARMA LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXCARBAZEPINE | OXCARBAZEPINE | TABLET;ORAL | 150MG | No | No |
| 002 | OXCARBAZEPINE | OXCARBAZEPINE | TABLET;ORAL | 300MG | No | No |
| 003 | OXCARBAZEPINE | OXCARBAZEPINE | TABLET;ORAL | 600MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219556-001 | OXCARBAZEPINE | OXCARBAZEPINE | 150MG | TABLET / ORAL | AB | 2026-03-02 | |
| A219556-002 | OXCARBAZEPINE | OXCARBAZEPINE | 300MG | TABLET / ORAL | AB | 2026-03-02 | |
| A219556-003 | OXCARBAZEPINE | OXCARBAZEPINE | 600MG | TABLET / ORAL | AB | 2026-03-02 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219556-001 | AB |
| A219556-002 | AB |
| A219556-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A219556-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | AB | 2026-03-02 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A219556-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | AB | 2026-03-02 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A219556-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | AB | 2026-03-02 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A219556-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | AB | 2026-03-02 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A219556-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | AB | 2026-03-02 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A219556-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | AB | 2026-03-02 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A219556-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | AB | 2026-03-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219556-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | AB | 2026-03-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219556-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | AB | 2026-03-02 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219556-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | AB | 2026-03-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219556-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | AB | 2026-03-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219556-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | AB | 2026-03-02 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219556-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | AB | 2026-03-02 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219556-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | AB | 2026-03-02 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219556-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | AB | 2026-03-02 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A219556-001 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A219556-002 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A219556-003 | AB | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A219556-001 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A219556-002 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A219556-003 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A219556-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219556-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219556-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219556-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219556-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219556-003 | AB | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219556-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219556-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219556-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxcarbazepine | OXCARBAZEPINE | Ascend Laboratories, LLC | 3f36f519-c30c-4929-afa0-9844dc531e3f | 2026-11-02 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Trileptal | OXCARBAZEPINE | Novartis Pharmaceuticals Corporation | 4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691b | 2026-10-28 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Umedica Laboratories USA Inc. | e46d4654-76bc-4c33-ac2b-e89ae11b7697 | 2026-10-23 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Zameer Pharmaceuticals LLC | 8841174a-9f4b-424f-a50d-01478f2aeb29 | 2026-10-23 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXTELLAR XR | OXCARBAZEPINE | Supernus Pharmaceuticals, Inc. | aa610e56-1d1d-11e1-8bc2-0800200c9a66 | 2026-10-05 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Biocon Pharma Inc. | 62dfed1d-4c5b-446d-97b3-bad9c33959ff | 2026-09-17 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Apotex Corp. | a20e4a95-8ee1-e702-003e-e353ec1ee133 | 2026-09-15 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Cardinal Health 107, LLC | 4ebcb0e5-1c93-4b3f-8749-6835c56afce5 | 2026-08-12 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | REMEDYREPACK INC. | a2032bcc-2da5-45e5-aa3f-ddbf50909df8 | 2026-08-05 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | REMEDYREPACK INC. | a90cd1f1-5258-4b0e-92fd-c4cebe47772b | 2026-08-04 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Aurobindo Pharma Limited | 21caded0-2ed7-4f7d-9856-27ef7c1a47c8 | 2026-07-30 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | ffc8d10c-0049-4fe5-beb8-79cc6a197ede | 2026-07-23 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | b571ee0f-3c2a-4c55-9c2b-e00014e2ec7a | 2026-07-21 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Cardinal Health 107, LLC | 3e0f8d9f-7659-4524-8f93-6200314356c8 | 2026-07-21 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | ANI Pharmaceuticals, Inc. | 867eaf99-3e31-4f75-bfae-2898804d956d | 2026-07-13 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | 85a9bdee-4d10-4097-ae3d-0bf8d844a11b | 2026-07-08 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | American Health Packaging | c0f9df3f-280e-4394-8d7e-ad04803b2635 | 2026-07-02 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Major Pharmaceuticals | b1d54def-057d-4608-bc8f-1d967ac3ec91 | 2026-06-15 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| oxcarbazepine | OXCARBAZEPINE | Zydus Lifesciences Limited | e23d8a74-b47b-462a-b09c-90bdd58a032e | 2026-06-13 | Warnings, Adverse reactions | oxcarbazepine OXCARBAZEPINE |
| oxcarbazepine | OXCARBAZEPINE | Zydus Pharmaceuticals (USA) Inc. | 5048dc87-2d89-434d-be51-4a97b0ce0601 | 2026-06-13 | Warnings, Adverse reactions | oxcarbazepine OXCARBAZEPINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.